Physician profile
Paula Johnson
NPI 1154415537
$6,069.06
in general payments reported to CMS, 2019-2025
14 companies · $2,862 in 2025
The $2,862 reported for 2025 was more than what 97% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $537 · 2022: $733 · 2023: $590 · 2024: $1,346 · 2025: $2,862.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,078 · Travel and Lodging: $1,720 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,078.08 |
| Travel and Lodging | $1,719.71 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,613.78 | 2021-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abiomed | $549.97 | 2024-2025 | Impella |
| Baxter Healthcare | $404.82 | 2023-2024 | Perclot, Preveleak, Floseal |
| Getinge USA Sales, LLC | $372.68 | 2021-2025 | Vasoview Hemopro 2 |
| Amgen INC. | $230.63 | 2023-2024 | Repatha |
| Csl Behring | $224.78 | 2021-2024 | Kcentra |
| Boston Scientific Corporation | $140.68 | 2024 | Watchman Access System |
| E.R. Squibb & Sons, L.L.C. | $115.21 | 2024 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $115.17 | 2023 | Jardiance |
| Emd Serono, INC. | $114.42 | 2021 | |
| Janssen Pharmaceuticals, INC | $107.04 | 2023 | Xarelto |
| Atricure, INC. | $35.29 | 2022 | |
| Medtronic, INC. | $25.86 | 2022 | |
| Neurelis, INC. | $18.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paula Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.